IMMUNOME INC (IMNM) Earnings History & Surprises

NASDAQ:IMNM • US45257U1088

23.52 USD

-0.26 (-1.09%)

Last: Apr 23, 2026, 11:50 AM

Past quarterly earnings results for IMMUNOME INC (IMNM), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Next Earnings Date

Upcoming

Release Date: May 7, 2026
Period: Q1 / 2026
EPS Estimate: -$0.57
Revenue Estimate: 226.664K

Last Reported

Most Recent

Release Date: Mar 3, 2026
Period: Q4 / 2025
EPS Reported: -$0.76
EPS Surprise: -23.77%
Revenue Surprise: -100.00%

Beat Rate

Last 8 Quarters

31%

EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

Quarter	EPS	EPS Est	EPS Surprise	EPS Q2Q	Revenue	Revenue Est	Revenue Surprise	Revenue Q2Q
Q4 2025	-0.76	-0.61	-23.77%	40.63%		306K	-100.00%	-100.00%
Q3 2025	-0.65	-0.59	-10.97%	16.67%		816K	-100.00%	-100.00%
Q2 2025	-0.50	-0.54	7.32%	16.67%	4.015M	728.576K	451.08%	69.84%
Q1 2025	-0.52	-0.69	25.15%	79.28%	2.926M	291.424K	904.03%	184.35%
Q4 2024	-1.28	-0.59	-116.80%	69.67%	2.738M	3.219M	-14.94%	-28.44%
Q3 2024	-0.78	-0.57	-36.96%	-349.83%	2.91M	2.176M	33.73%	-18.49%
Q2 2024	-0.60	-0.40	-49.55%	-30.43%	2.364M	2.601M	-9.11%	-44.55%
Q1 2024	-2.51	-0.71	-254.68%	-617.14%	1.029M	2.856M	-63.97%	-
Q4 2023	-4.22	-0.29	-1,360.22%	-559.37%	3.826M	2.111M	81.24%	-
Q3 2023		-0.17	-	76.88%	3.57M		-	-
Q2 2023	-0.46	-0.16	-181.86%	37.84%	4.263M		-	-
Q1 2023	-0.35	0.60	-158.66%	63.54%	2.36M		-	-
Q4 2022	-0.64	-0.69	7.04%	5.88%			-	-
Q3 2022	-0.75	-0.78	3.25%	-15.38%			-	-
Q2 2022	-0.74	-0.77	3.27%	-60.87%			-	-
Q1 2022	-0.96	-0.70	-36.40%	-159.46%			-	-
Q4 2021	-0.68	-0.83	17.70%	-70.00%			-	-
Q3 2021	-0.65	-0.51	-27.45%	91.36%			-	-
Q2 2021	-0.46	-0.40	-15.64%	-		3.857M	-100.00%	-
Q1 2021	-0.37	-0.42	11.53%	-		2.639M	-100.00%	-
Q4 2020	-0.40	-0.30	-35.23%	-		2.142M	-100.00%	-
Q3 2020	-7.52	-0.39	-1,840.14%	-		398.31K	-100.00%	-
Q2 2020			-	-			-	-

Notes

EPS and Revenue values are non-GAAP when available, otherwise GAAP.
Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

Revenue Historical Q2Q growth and Acceleration

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)

Average EPS beat (4)

-0.57%

Max EPS beat (4)

25.15%

Min EPS beat (4)

-23.77%

Revenue beat statistics

Revenue beat (4)

Average Revenue beat (4)

288.78%

Max Revenue beat (4)

904.04%

Min Revenue beat (4)

-100.00%

Analysis

In the last 4 quarters, IMNM has beaten EPS estimates in 2 out of 4 releases

IMNM has beaten revenue estimates in 2 out of the last 4 releases

In the last 4 quarters, IMNM reported -0.6% below the EPS estimates on average.

In the last 4 quarters, IMNM has beaten the revenue estimates by 288.8% on average.

IMNM Overview IMNM Technical Analysis Report IMNM Fundamental Analysis Report IMNM Forecast & Price Target

→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

IMMUNOME INC / IMNM Earnings FAQ

When did IMMUNOME INC (IMNM) report earnings last quarter?

IMMUNOME INC (IMNM) last reported earnings on 3/3/2026.

Did IMNM stock beat earnings estimates in the most recent quarter?

IMMUNOME INC (IMNM) missed EPS estimates and missed revenue estimates in the most recent quarter.

How often does IMMUNOME INC (IMNM) beat earnings estimates?

In the last 4 quarters, IMMUNOME INC (IMNM) has beaten EPS estimates in 2 out of 4 releases.

IMNM Earnings overview

Earnings Snapshot